MSante
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
MSante - overview
Established
2013
Location
-, -, France
Primary Industry
Healthcare
About
Based in France and founded in 2013, MSante is a home healthcare service provider specialising in infusion and nutrition. Stephane Freche is the founder of the company. In July 2021, Damartex acquired an 80% majority stake in MSante. The company provides services such as patient care, reassuring patients when there are still questions regarding the coordination of care and pathological monitoring while returning home, and establishing a link between the city and the hospital to allow communication about the patient.
The firm also provides support protocols including perfusion (antibiotics, hydration), hyperhydration, enteral and parenteral nutrition, pain, post-op pain protocol in orthopedic surgery (KTPN, Ketamine), chemotherapy, chronic wounds (dressings), orthopedics, medical material, neurological pathologies (MS, Parkinson, ALS), respiratory pathologies, immunoglobulin, and pediatric management protocol (pyelonephritis, nutrition).
Current Investors
Damartex Group
Primary Industry
Healthcare
Sub Industries
Home Healthcare, Nursing Homes & Assisted Living, Chiropractic, Orthopedic & Physical Therapy
Website
www.msante.org
Company Stage
Add-on
Total Amount Raised
Subscriber access only
MSante - timeline of key events
MSante - financials
| Fiscal Year Ended | Nov 30, 2017 | Nov 30, 2018 | Nov 30, 2019 | Nov 30, 2020 | Nov 30, 2021 | Nov 30, 2022 | Jun 30, 2023 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | 1,400,483 | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - |
| EBITDA (USD) | - | - | - | 93,659 | - | - | - | - |
| Operating Income (USD) | - | - | - | 72,991 | - | - | - | - |
| Operating Margin | - | - | - | 5.2% | - | - | - | - |
| % EBITDA Margin | - | - | - | 6.7% | - | - | - | - |
| NET Income (USD) | 118,841 | 14,545 | 161,324 | 46,535 | - | - | - | - |
| % Net Margin | - | - | - | 3.3% | - | - | - | - |
MSante - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | MSante | - |
Displaying 1 - 1 of 1
MSante - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.